UBS AM’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-151,896
Closed -$478K 2631
2020
Q3
$478K Hold
151,896
﹤0.01% 2166
2020
Q2
$442K Sell
151,896
-14,433
-9% -$42K ﹤0.01% 2168
2020
Q1
$469K Buy
166,329
+7,076
+4% +$20K ﹤0.01% 2001
2019
Q4
$517K Buy
159,253
+27,919
+21% +$90.6K ﹤0.01% 2223
2019
Q3
$284K Buy
131,334
+9,953
+8% +$21.5K ﹤0.01% 2475
2019
Q2
$381K Hold
121,381
﹤0.01% 2324
2019
Q1
$452K Buy
121,381
+23,561
+24% +$87.6K ﹤0.01% 2146
2018
Q4
$284K Sell
97,820
-1,027
-1% -$2.98K ﹤0.01% 2233
2018
Q3
$260K Sell
98,847
-4,266
-4% -$11.2K ﹤0.01% 2328
2018
Q2
$241K Hold
103,113
﹤0.01% 2394
2018
Q1
$303K Sell
103,113
-40,052
-28% -$118K ﹤0.01% 2209
2017
Q4
$392K Buy
143,165
+5,293
+4% +$14.5K ﹤0.01% 2048
2017
Q3
$467K Hold
137,872
﹤0.01% 1969
2017
Q2
$341K Hold
137,872
﹤0.01% 1983
2017
Q1
$313K Buy
137,872
+54,883
+66% +$125K ﹤0.01% 1997
2016
Q4
$176K Sell
82,989
-32,500
-28% -$68.9K ﹤0.01% 2156
2016
Q3
$387K Hold
115,489
﹤0.01% 2128
2016
Q2
$362K Hold
115,489
﹤0.01% 2133
2016
Q1
$385K Sell
115,489
-90,734
-44% -$302K ﹤0.01% 2072
2015
Q4
$730K Buy
206,223
+4,200
+2% +$14.9K ﹤0.01% 1869
2015
Q3
$1.02M Buy
202,023
+16,182
+9% +$81.4K ﹤0.01% 1718
2015
Q2
$1.2M Buy
185,841
+25,076
+16% +$161K ﹤0.01% 1620
2015
Q1
$1.13M Buy
160,765
+45,000
+39% +$317K ﹤0.01% 1584
2014
Q4
$893K Buy
115,765
+5,400
+5% +$41.7K ﹤0.01% 1637
2014
Q3
$825K Buy
110,365
+15,500
+16% +$116K ﹤0.01% 1627
2014
Q2
$918K Buy
94,865
+4,700
+5% +$45.5K ﹤0.01% 1610
2014
Q1
$749K Buy
90,165
+49,969
+124% +$415K ﹤0.01% 1669
2013
Q4
$339K Sell
40,196
-1,400
-3% -$11.8K ﹤0.01% 2043
2013
Q3
$332K Hold
41,596
﹤0.01% 2021
2013
Q2
$321K Buy
+41,596
New +$321K ﹤0.01% 1956